Diverse Alterations of Glomerular Capillary Networks in Focal Segmental Glomerular Sclerosis. 2022

Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
Department of Nephrology, Adachi Iriya Toneri Clinic, Tokyo, Japan.

Focal segmental glomerular sclerosis (FSGS) is caused by podocyte injury. It is characterized by obliteration of glomerular capillary tufts with increased extracellular matrix (ECM). Altered communication between podocytes and glomerular endothelial cells (ECs) contributes to sclerosis progression. We focused on EC injury in the FSGS. A total of 29 FSGS and 18 control biopsy specimens were assessed for clinicopathologic characteristics. CD34 (a marker for EC)-positive capillaries and ECM accumulation were evaluated quantitatively for each variant using computer-assisted image analysis. The estimated glomerular filtration rate (eGFR) in the FSGS group was significantly lower than that in the control group. The frequency of FSGS variants was 51.7% for cellular; 13.8% for perihilar (PH), tip, and not otherwise specified (NOS); and 6.9% for collapsing. Regarding sclerotic lesions in all FSGS, narrowing or loss of CD34-positive capillaries was observed. Electron microscopy results showed loss of fenestrae, subendothelial space enlargement, and cytoplasmic swelling, indicating EC injury. Computer-assisted image analysis revealed significantly smaller areas of glomerular capillaries in FSGS with or without sclerotic lesions, with increased ECM. Moreover, in comparison with each variant, narrowed capillaries and ECM accumulation were most prominent in the collapsing variant, whereas the tip variant had the least change. EC injury was observed in all FSGS cases, not only in sclerotic lesions but also in nonsclerotic lesions. Severity of EC injury may vary in each variant due to diverse alterations of glomerular capillary networks.

UI MeSH Term Description Entries

Related Publications

Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
January 1996, Kidney international. Supplement,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
December 1985, Kidney international,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
October 2004, Nihon rinsho. Japanese journal of clinical medicine,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
June 1980, The American journal of medicine,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
December 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
January 2013, Contributions to nephrology,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
May 2001, Clinical nephrology,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
March 1987, Nihon Jinzo Gakkai shi,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
February 2024, Kidney international,
Megumi Morita, and Akiko Mii, and Fumihiko Yasuda, and Yusuke Arakawa, and Tetsuya Kashiwagi, and Akira Shimizu
September 1986, Medicine,
Copied contents to your clipboard!